(NP (NP-COOD (NP (NP (NN Transactivation)) (PP (IN of) (NP (DT the) (JJ human) (NN immunodeficiency) (NN virus) (NN promoter))) (PP (IN by) (NP (NP (NP (NP (JJ human) (NN herpesvirus) (CD 6)) (PRN (-LRB- -LRB-) (NP (NN HHV-6)) (-RRB- -RRB-))) (VBZ strains)) (NP-COOD (NP (NN GS)) (CC and) (NP (NN Z-29))))) (PP (IN in) (NP (JJ primary) (JJ human) (NN T) (NNS lymphocytes)))) (CC and) (NP (NP (NN identification)) (PP (IN of) (NP (VBG transactivating) (NN HHV-6) (-LRB- -LRB-) (NN GS) (-RRB- -RRB-) (NN gene) (NNS fragments))))) (. .))
(S (NP-SBJ (NP (JJ Human) (NN herpesvirus) (CD 6)) (PRN (-LRB- -LRB-) (NP (NN HHV-6)) (-RRB- -RRB-))) (VP (MD can) (VP (VP-COOD (VP (VB activate) (NP (DT the) (NP (NP (JJ human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (NN promoter))) (CC and) (VP (VB accelerate) (NP (JJ cytopathic) (NNS effects)))) (PP (IN in) (NP (JJ HIV-infected) (JJ human) (NN T) (NNS cells))))) (. .))
(S (NP-SBJ (DT This) (NN study)) (VP (VBZ examines) (NP (NP (DT the) (NNS regions)) (PP (IN of) (NP (DT the) (NN HIV) (NN promoter))) (VP (VBN required) (NP (-NONE- *)) (PP (IN for) (NP (NP (NN HHV-6) (NN transactivation)) (PP (IN in) (NP (NP (DT a) (JJ heterogeneous) (NN population)) (PP (IN of) (NP (JJ primary) (JJ human) (NN T) (NNS lymphocytes))))) (PP (PP-COOD (PP (IN with) (NP (-NONE- *RNR*-36))) (CC or) (PP (IN without) (NP (-NONE- *RNR*-36)))) (NP-36 (JJ antigenic) (NN stimulation)))))))) (. .))
(S (NP-SBJ (NP (NP (CD Two) (JJ different) (NNS strains)) (PP (IN of) (NP (NN HHV-6)))) (, ,) (NP-COOD (NP (NN GS)) (CC and) (NP (NN Z29))) (, ,)) (VP (VBD transactivated) (NP (DT the) (NN HIV) (NN promoter))) (. .))
(S (NP-SBJ (DT The) (NN GS) (NN strain)) (VP (VBD transactivated) (NP (DT the) (NN promoter)) (PP (IN in) (NP (ADJP-COOD (CC both) (ADJP (VBN stimulated)) (CC and) (ADJP (VBG resting))) (NN T) (NNS cells))) (, ,) (SBAR (IN while) (S (NP-SBJ (DT the) (NN Z29) (NN strain)) (VP (VBD increased) (NP (NN HIV) (NN promoter) (NN activity)) (PP (RB only) (IN in) (NP (VBN stimulated) (NN T) (NNS cells))))))) (. .))
(S (NP-SBJ (NP (CD Three) (NN DNA) (NNS clones)) (VP (VBG containing) (NP (NN HHV-6) (-LRB- -LRB-) (NN GS) (-RRB- -RRB-) (JJ genomic) (NNS fragments)))) (VP (VBD transactivated) (NP (NP (DT the) (NN HIV) (NN promoter)) (PP (IN in) (NP (VBN cotransfected) (NN T) (NNS cells))))) (. .))
(S (NP-SBJ (NP (DT A) (JJ 21.4-kb) (NN DNA) (NN clone)) (, ,) (NP (NN pZVB70)) (, ,)) (VP (VBD showed) (NP (DT the) (JJS highest) (NN transactivating) (NN ability)) (, ,) (SBAR (IN while) (S (NP-SBJ (NP (CD two) (JJ other) (NN DNA) (NNS fragments)) (, ,) (NP-COOD (NP (NP (NN pZVB10)) (PRN (-LRB- -LRB-) (NP (CD 6.2) (NN kb)) (-RRB- -RRB-))) (CC and) (NP (NP (NN pZVH14)) (PRN (-LRB- -LRB-) (NP (CD 8.7) (NN kb)) (-RRB- -RRB-)))) (, ,)) (VP (VBD showed) (NP (JJR lower) (NN activity)))))) (. .))
(S (NP-SBJ (NP (NP (CD One)) (PP (IN of) (NP (DT these) (NNS clones)))) (, ,) (NP (NN pZVH14)) (, ,)) (VP (VBD activated) (NP (NP (DT the) (NN HIV) (NN promoter) (NN construct)) (VP (VBG containing) (NP (DT a) (NN mutation)) (PP (IN in) (NP (DT the) (NN NF) (NN kappa) (NN B) (NN site)))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-38 (DT this) (VBN mutated) (NN NF) (NN kappa) (NN B) (NN promoter)) (VP (VBD was) (RB not) (VP (VBN transactivated) (NP (-NONE- *-38)) (PP-TMP-COOD (PP (IN during) (NP (NN HHV-6) (-LRB- -LRB-) (NN GS) (-RRB- -RRB-) (NN infection))) (CC or) (PP (IN after) (NP (NP (NN cotransfection)) (PP (IN with) (NP-COOD (NP (NN pZVB70)) (CC or) (NP (NN pZVB10))))))))) (. .))
(S (NP-SBJ (DT These) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN NF) (NN kappa) (NN B) (NNS sites)) (PP (IN of) (NP (DT the) (NN HIV) (NN promoter)))) (VP (VBP are) (ADJP-PRD (JJ essential) (PP (IN for) (NP (NP (PRP$ its) (NN transactivation)) (PP-TMP (IN during) (NP (NN HHV-6) (-LRB- -LRB-) (NN GS) (-RRB- -RRB-) (NN infection)))))))))) (. .))
(S (PP (IN By) (S (NP-SBJ (-NONE- *-39)) (VP (VBG increasing) (NP (NP (NN HIV) (NN promoter) (NN activity)) (PP (IN in) (NP (JJ primary) (NN T) (NNS lymphocytes))))))) (, ,) (NP-SBJ-39 (NN HHV-6)) (VP (MD may) (ADVP (RB consequently)) (VP (VB increase) (NP (NN HIV) (NN replication)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG leading) (PP (TO to) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ cytopathic) (NN effect)) (PP (IN on) (NP (VBN coinfected) (JJ human) (NN T) (NNS cells))))))))))) (. .))
